Heading. Heading AGENDA – Date.

Slides:

Advertisements

Similar presentations

Innovations in Structured Products October 25, 2010 An Innovator’s Dilemma?

Advertisements

High Risk Investment Disclaimer Trading foreign exchange on margin carries a high level of risk, and may not be suitable for all investors. The high degree.

Martin Arnold Director - Research Analyst ETF Securities.

STRICTLY CONFIDENTIAL Positioning for Growth Tasmanian Strata Industry Tim MacKenzie Associate Director Friday 9 th August.

1 World Grain & Oilseed Outlook March Summary –Corn Acreage Exhale Export Expansion?? Funds big buyers. SA Crop Shrinking Bearish Bias - $3.50.

The Demand and Supply of High Quality Liquid Collateral Post Financial Crisis Discussion at PBOC/Tsinghua Global Finance Forum The views expressed in this.

Managing HFAs’ Financial Health in the Face of Uncertainty NCSHA Annual Conference October 21, 2014 Ping Hsieh, Vice President – Senior Analyst.

AUDIT COMMITTEES What are they and why are they beneficial?

Client Update September 2013 Andrew Tasker – GFM Representative WA.

Anticipated 2008 Generic Launches JULY 2008 David Harding, API Intelligence, Thomson Reuters Source: FDA, NEWPORT HORIZON PREMIUM TM © THOMSON REUTERS.

Copyright 2011, Atmel December, 2011 Atmel ARM-based Flash Microcontrollers 1 1.

10 years of success - now the real challenge begins

PRODUCTIVITY – THE PICTURE FOR THE UK & THE WEST MIDLANDS SUSTAINING COMPETITIVENESS CONFERENCE – THE BELFRY RHYS HERBERT SENIOR ECONOMIST 6 JULY 2012.

MESSAGING IN THE MEDIA TOP 10 DRUGS BASED ON CREDIBILITY INDEX IN THE LITERATURE JOHN KNAPP, DIRECTOR OF ANALYTICS MAY 2009 Your use of these materials.

Therapeutic area breakdown of lead projects in development for first launch in 2005 APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM ©

Paragraph IV Patent Challenges – As of July 1, 2008 JULY 2008 David Harding, API Intelligence, Thomson Reuters Source: FDA, NEWPORT HORIZON PREMIUM TM.

Mr. Amit Chheda (Strategist)

Proportion of biotech-derived active substances in development for first launch 31st December APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE.

Deloitte Forensic Forensic Technology Conference of Regulatory Officers - CORO November 2012.

Place Client Logo Here Oil Market Outlook Paul Horsnell Head of Commodities Research, Barclays Capital Intertanko Singapore Tanker Event 30 March 2006.

Proportion of total R&D expenditure by therapeutic area in 2005 APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM © THOMSON REUTERS Your.

Global R&D expenditure, development times, global pharmaceutical sales and new molecular entity output MARCH 2008 SOURCE: CMR INTERNATIONAL.

2005/2006 Expenditure on biotech derived entities had remained constant APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM © THOMSON REUTERS.

Number of pharmaceutical patent applications and granted patents for 5 major patent issuing authorities JUNE 2008 SOURCE: DERWENT WORLD PATENTS.

Regulatory approval times between submission and marketing authorization approval APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM.

Availability of High-Quality API for India, China and Rest of World MARCH 2008 David Harding, API Intelligence, Thomson Reuters Source: NEWPORT HORIZON.

Allocation of R&D expenditure in 2005 between chemical entity and biological or biotech active substances APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE.

Stock trading Vs Options EXPLORING FUNDAMENTALS Amit Shanker

London CLT Big Potential Presentation 17 th March 2016.

The economic outlook. 2 Greece Russia 3 The deflation-ghost.

The secure site rendering issue (all navigation crushed together as a list at the top of the page) is a compatibility issue with Internet Explorer only.

Colin George 30 March 2016 Export Finance for SMEs.

To us there are no foreign markets. ™ Understanding Your Employee Stock Option Plan June 2014 To us there are no foreign markets. ™

01 Autofacts 2011 Q1 Autofacts ® SWOT analysis Alliance Group ? 200? Q?

Dr. Maya Bundt, Head Cyber & Digital Strategy, Swiss Re

HRMS At India Infoline 2008.

RaboDirect Financial Health Barometer 2016

Mountain Plains Housing Summit 2016

LMEprecious – London’s Gold and Silver futures

BIOLOGY / CHEMISTRY CITATIONS GROWTH

Rising Momentum Trumps Policy Uncertainty

Protect your Business April 2018

Lesley Stewart Wealth Manager, Gauteng Qualifications

Mark Bennett, Head of Agribusiness, ANZ

Messaging in the Media TOP 10 AUDIENCES BY THERAPY AREA

The Demand and Supply of High Quality Liquid Collateral Post Financial Crisis Discussion at PBOC/Tsinghua Global Finance Forum by Jian Hu, Managing Director,

, R&D expenditure showed 6% growth annually

Jon Gamble Head of Intermediaries September 2018

Danie Jansen van Vuuren

Market linked debentures

Become a successful exporter

Business Name Reg No.____________ Team Member 1_________

Fairtree Overview.

Heading. Heading GLACIER FINANCIAL SOLUTIONS (PTY) LTD IS A LICENSED FINANCIAL SERVICES PROVIDER. Any information contained in this presentation.

ประกาศกระทรวงอุตสาหกรรม ฉบับที่ 5292 (พ.ศ. 2562)

AGENDA – Date Heading.

SLIDE TITLE Presented by. SLIDE TITLE Presented by.

SLIDE TITLE Presented by. SLIDE TITLE Presented by.

Heading Presented by. heading Presented by AGENDA.

GLACIER FINANCIAL SOLUTIONS (PTY) LTD IS A LICENSED FINANCIAL SERVICES PROVIDER. Any information contained in this presentation as well as.

AGENDA – Date. AGENDA – Date Heading.

Nimbus fixed option by Presented by. Nimbus fixed option by Presented by.

SLIDE TITLE Presented by. SLIDE TITLE Presented by.

SLIDE TITLE Presented by. SLIDE TITLE Presented by.

SLIDE TITLE Presented by. SLIDE TITLE Presented by.

Nimbus fixed option by Presented by. Nimbus fixed option by Presented by.

Oxford Village Tenancy Plan Paul Trachtenberg

AGENDA. AGENDA SLIDE TITLE Presented by.

Financial Performance Report

Presentation transcript:

Heading

AGENDA – Date

GLACIER FINANCIAL SOLUTIONS (PTY) LTD IS A LICENSED FINANCIAL SERVICES PROVIDER. The information in this presentation is provided for information purposes only and should not be construed as the rendering of advice to clients. Although we have taken reasonable steps to ensure the accuracy of the information, neither Sanlam nor any of its subsidiaries accept any liability whatsoever for any direct, indirect or consequential loss arising from the use of, or reliance in any manner on the information provided in this document. June 2018 Glacier Financial Solutions (Pty) Ltd. | A member of the Sanlam Group | Private Bag X5 | Tyger Valley 7536 | Email client.services@glacier.co.za | Tel +27 21 917 9002 / 0860 452 364 | Fax +27 21 947 9210 | Web www.glacier.co.za | Twitter @GlacierBySanlam | Reg No1999/025360/07 | Licensed Discretionary Financial Services Provider. FSP 770 trading as Glacier Invest. Sanlam Multi-Manager International (Pty) Ltd. | A member of the Sanlam Group | Private Bag X8 | Tyger Valley 7536 | Tel +27 21 950 2600 | Fax +27 21 950 2126 | Web www.smmi.com | Reg No 2002/030939/07 | Discretionary Financial Services Provider, acting as Juristic Representative under the Glacier Financial Solutions FSP 770.